Countries citing papers authored by A. N. Serafini
Since
Specialization
Citations
This map shows the geographic impact of A. N. Serafini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. N. Serafini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. N. Serafini more than expected).
This network shows the impact of papers produced by A. N. Serafini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. N. Serafini. The network helps show where A. N. Serafini may publish in the future.
Co-authorship network of co-authors of A. N. Serafini
This figure shows the co-authorship network connecting the top 25 collaborators of A. N. Serafini.
A scholar is included among the top collaborators of A. N. Serafini based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A. N. Serafini. A. N. Serafini is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Serafini, A. N.. (2001). Therapy of metastatic bone pain.. PubMed. 42(6). 895–906.157 indexed citations
4.
Wegener, William A., Nicholas J. Petrelli, A. N. Serafini, & D M Goldenberg. (2000). Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration.. PubMed. 41(6). 1016–20.16 indexed citations
Serafini, A. N., K. S. Sridhar, Kemal Peker, et al.. (1998). Somatostatin receptor expression in Hürthle cell cancer of the thyroid.. PubMed. 39(2). 243–5.27 indexed citations
8.
Dewanjee, Mrinal K., et al.. (1994). Kinetics of hybridization of mRNA of c-myc oncogene with In-III labeled antisense deoxyoligonucleotide (INASDON) probes by high pressure chromatography technique. 35. 353–355.1 indexed citations
9.
Dewanjee, Mrinal K., et al.. (1994). Effect of radionuclide on membrane-transport and intracellular hybridization of c-myc probe in cultured murine leukemic cells. 35. 294–296.1 indexed citations
10.
Goldenberg, David M., Robert M. Sharkey, Edward B. Silberstein, et al.. (1993). Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.. PubMed. 34(1). 61–70.31 indexed citations
11.
Schelbert, Heinrich, Robert O. Bonow, Edward M. Geltman, et al.. (1993). Position statement: clinical use of cardiac positron emission tomography. Position paper of the Cardiovascular Council of the Society of Nuclear Medicine.. PubMed. 34(8). 1385–8.8 indexed citations
12.
Dewanjee, Mrinal K., Mansoor Kapadvanjwala, Awtar Krishan, et al.. (1993). Radiolabeled antisense oligodeoxynucleotides: In vitro and in vivo applications. 16(4). 276–289.3 indexed citations
Serafini, A. N., et al.. (1992). Clinical comparison of technetium-99m-teboroxime and thallium-201 utilizing a continuous SPECT imaging protocol.. PubMed. 33(7). 1304–11.6 indexed citations
Zusmer, N R, et al.. (1978). Gray scale ultrasonography and rose bengal scintigraphy in the evaluation of the patient with jaundice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 147(3). 321–7.3 indexed citations
19.
Serafini, A. N., et al.. (1975). Iodine-123-Rose bengal: An improved hepatobiliary imaging agent.. PubMed. 16(7). 629–32.11 indexed citations
20.
Serafini, A. N., et al.. (1974). Radionuclide breast scanning in carcinoma of the breast.. PubMed. 15(12). 1149–52.21 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.